BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 6228745)

  • 21. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.
    Marx A; Pfister F; Schalke B; Saruhan-Direskeneli G; Melms A; Ströbel P
    Autoimmun Rev; 2013 Jul; 12(9):875-84. PubMed ID: 23535159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients.
    Heidenreich F; Vincent A; Willcox N; Newsom-Davis J
    Neurology; 1988 Nov; 38(11):1784-8. PubMed ID: 3185915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scenarios for autoimmunization of T and B cells in myasthenia gravis.
    Shiono H; Roxanis I; Zhang W; Sims GP; Meager A; Jacobson LW; Liu JL; Matthews I; Wong YL; Bonifati M; Micklem K; Stott DI; Todd JA; Beeson D; Vincent A; Willcox N
    Ann N Y Acad Sci; 2003 Sep; 998():237-56. PubMed ID: 14592881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood cells: role of suppressor T cells in normal subjects.
    Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR; Witte A
    Neurology; 1984 Jun; 34(6):802-5. PubMed ID: 6233499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity.
    Berrih-Aknin S; Cohen-Kaminsky S; Lepage V; Neumann D; Bach JF; Fuchs S
    J Autoimmun; 1991 Feb; 4(1):137-53. PubMed ID: 2031657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.
    Fujii Y; Monden Y; Hashimoto J; Nakahara K; Kawashima Y
    Clin Immunol Immunopathol; 1985 Jan; 34(1):141-6. PubMed ID: 4038384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4
    Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
    Front Immunol; 2020; 11():809. PubMed ID: 32508812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-lymphocytes in experimental autoimmune myasthenia gravis. Isolation of T-helper cell lines.
    Hohlfeld R; Kalies I; Ernst M; Ketelsen UP; Wekerle H
    J Neurol Sci; 1982 Dec; 57(2-3):265-80. PubMed ID: 6186772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.
    Pachner AR; Kantor FS; Mulac-Jericevic B; Atassi MZ
    Immunol Lett; 1989 Feb; 20(3):199-204. PubMed ID: 2469649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.
    Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S
    Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions.
    Newsom-Davis J; Willcox N; Scadding G; Calder L; Vincent A
    Ann N Y Acad Sci; 1981; 377():393-402. PubMed ID: 6978662
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
    Melms A; Weissert R; Klinkert WE; Schalke BC; Tzartos S; Wekerle H
    Neurology; 1993 Mar; 43(3 Pt 1):583-8. PubMed ID: 7680803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and functional characterization of T cells from patients with myasthenia gravis.
    Mokhtarian F; Pino M; Ofosu-Appiah W; Grob D
    J Clin Invest; 1990 Dec; 86(6):2099-108. PubMed ID: 1979338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.